Alliance Pharma (APH)

 

APH Share PerformanceMore

52 week high53.50 14/09/16
52 week low40.50 27/06/16
52 week change 1.63 (3.54%)
4 week volume21,134,622 26/04/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Application for admission

RNS Number: 8161F Alliance Pharma PLC 22 May 2017 For immediate release 22 May 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Application for admission Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that following the exercise of employee share options, application has been made by Alliance for a fur...

Fund manager's favourite small-cap pharma shares

If you're looking for capital growth, don't bother with big pharma, argues fund manager Paul Mumford. He tells Lee Wild...

Broker Forecast - finnCap issues a broker note on Alliance Pharma PLC

finnCap today initiates coverage of Alliance Pharma PLC (LON:APH) with a buy investment rating and price target of 65...

Application for admission

RNS Number: 4932E Alliance Pharma PLC 08 May 2017 For immediate release 8 May 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Application for admission Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that following the exercise of employee share options, application has been made by Alliance for a fur...

Application for admission

RNS Number: 3936E Alliance Pharma PLC 05 May 2017 For immediate release 5 May 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Application for admission Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that following the exercise of employee share options, application has been made by Alliance for a furt...

Changes to interests of a significant shareholder

RNS Number: 2919E Alliance Pharma PLC 05 May 2017 For immediate release 5 May 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Changes to interests of a significant shareholder Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, has received a notification of a change in the interests of a significant shareholder. In accord...

Changes to interests of a significant shareholder

RNS Number: 2920E Alliance Pharma PLC 05 May 2017 For immediate release 5 May 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Changes to interests of a significant shareholder Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, has received a notification of a change in the interests of a significant shareholder. In accord...

Changes to interests of a significant shareholder

RNS Number: 2177E Alliance Pharma PLC 04 May 2017 For immediate release 4 May 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Changes to interests of a significant shareholder Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, has received a notification of a change in the interests of a significant shareholder. In accord...

Fundamental DataMore

P/E ratio12.338
EPS3.85
Dividend yield2.547 %

Equity Research (APH)

Alliance Pharma plc
01/02/2017
Early Equity (EEQP.NEX) 1.1p £7m FY Aug 16 results from the UK investment Company that provides equity and debt capital, along with strategic and operational counsel, to businesses that have the...
hardman & co
Alliance Pharma plc
25/01/2017
Alliance Pharma’s buy-and-build strategy to evolve into a profitable, cash generative, specialty pharma business is clearly bearing fruit. Acquisition of the dermatology and woundcare products from...
hardman & co
Alliance Pharma plc
07/06/2016
Alliance Pharma has adopted a buy-and-build strategy to evolve through a series of 28 acquisitions into a profitable, cash generative, specialty pharma business. The acquisition of part of the...

Latest discussion posts More

  • Re: Cheap, cheap, cheap.

    Claude - Your thoughts are the same as mine - where did these shares go? If the purchasers (could be a few) did not increase or create a holding above 3% then no ...
    4-May-2017
    winningstreak
  • Re: Cheap, cheap, cheap.

    How do you view the major sales of shares by Aveva and Nigel Wray, without currently a balancing statement about share increases held by other institutions? Would be ...
    4-May-2017
    claude reins
  • Cheap, cheap, cheap.

    At 47.75p the share here are cheap, cheap, cheap. I preached for long enough that the shares at INSE were cheap, they now a fair bit dearer, although still quite cheap. I ...
    26-Apr-2017
    winningstreak

Users' HoldingsMore

Users who hold Alliance Pharma also hold..
LLOYDS GRP.26%
BP19%
NATIONAL GRID17%
GLAXOSMITHKLINE16%
TESCO13%

Codes & Symbols

ISINGB0031030819
SymbolsAPH, LSE:APH, APH.L, APH:LN, LON:APH, XLON:APH